Impel Pharmaceuticals Inc
IMPLCIK 0001445499 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Mar 31, 2023. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0066
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Impel Pharmaceuticals Inc
| Name | Roles | Filings |
|---|---|---|
| Kalb Michael Wayne | Officer | 1 |
| Oaktree Az Strategic Lending Fund, L.P. | 10% Owner | 1 |
| Oaktree Capital Group, LLC | 10% Owner | 1 |
| Oaktree Diversified Income Fund Inc. | 10% Owner | 1 |
| Oaktree Gcp Fund Delaware Holdings, L.P. | 10% Owner | 1 |
All filings
30 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|